BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 475643)

  • 21. Evaluation of tumor angiogenesis factor with the rabbit cornea model.
    Ryu S; Albert DM
    Invest Ophthalmol Vis Sci; 1979 Aug; 18(8):831-41. PubMed ID: 457356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of neovascularization in relation to diabetic and other proliferative retinopathies.
    Patz A; Lutty G; Bennett A; Coughlin WR
    Trans Am Ophthalmol Soc; 1978; 76():102-7. PubMed ID: 754366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis inhibitors and their delivery systems.
    Langer R; Murray J
    Appl Biochem Biotechnol; 1983 Feb; 8(1):9-24. PubMed ID: 6206793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal neovascularization.
    Archer DB
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():2-27. PubMed ID: 6197789
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiogenic activity of vitreous and retinal extract.
    Chen CH; Chen SC
    Invest Ophthalmol Vis Sci; 1980 Jun; 19(6):596-602. PubMed ID: 6155359
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors.
    Gimbrone MA; Leapman SB; Cotran RS; Folkman J
    J Natl Cancer Inst; 1973 Jan; 50(1):219-28. PubMed ID: 4692862
    [No Abstract]   [Full Text] [Related]  

  • 28. The inhibition of corneal vascularization with aortic extracts in rabbits.
    Eisenstein R; Goren SB; Shumacher B; Choromokos E
    Am J Ophthalmol; 1979 Dec; 88(6):1005-12. PubMed ID: 92893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenic activity of vitreous extract obtained from rabbit eyes with endotoxin-induced uveitis.
    Naveh N; Nussbaum A; Desatnik H; Bartov E
    Ophthalmic Res; 1995; 27(1):23-31. PubMed ID: 7596556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
    Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
    Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-induced neovascularization in the mouse eye.
    Muthukkaruppan VR; Kubai L; Auerbach R
    J Natl Cancer Inst; 1982 Sep; 69(3):699-708. PubMed ID: 6180212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of vascular proliferation to tumor growth.
    Folkman J; Cotran R
    Int Rev Exp Pathol; 1976; 16():207-48. PubMed ID: 783062
    [No Abstract]   [Full Text] [Related]  

  • 34. Establishment of a tumor neovascularization animal model with biomaterials in rabbit corneal pouch.
    Chu YP; Li HC; Ma L; Xia Y
    Life Sci; 2018 Jun; 202():98-102. PubMed ID: 29577878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma.
    Levine HA; Pamuk S; Sleeman BD; Nilsen-Hamilton M
    Bull Math Biol; 2001 Sep; 63(5):801-63. PubMed ID: 11565406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of melanoma-associated neoangiogenesis by bevacizumab.
    Jaissle GB; Ulmer A; Henke-Fahle S; Fierlbeck G; Bartz-Schmidt KU; Szurman P
    Arch Dermatol; 2008 Apr; 144(4):525-7. PubMed ID: 18427047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticomplementary activity of cornea, vitreous and chorioretina in rabbits.
    Liao HR; Minta JO; Basu PK
    Can J Ophthalmol; 1979 Oct; 14(4):270-3. PubMed ID: 261667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of tumor angiogenesis mediated by cartilage.
    Brem H; Folkman J
    J Exp Med; 1975 Feb; 141(2):427-39. PubMed ID: 1113064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Isolation and characteristics of the neovascularization inhibitor from the vitreous body].
    Lisniak IA
    Vopr Med Khim; 1988; 34(2):16-8. PubMed ID: 3400186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.